VolitionRX Ltd. VNRX 深 滬
等待開盤 12-19 09:30:00 美东时间
0.2674
+0.000
+0.11%
華盛通- 最 高0.2789
- 今 開0.2755
- 成交量 352.99万股
- 最 低 0.2505
- 昨 收 0.2671
- 總市值 3289.02万
- 52周最高 0.94
- 市盈率 靜 --
- 換手率 2.87%
- 52周最低 0.2335
- 委 比 41.46%
- 總股本 1.23亿
- 歷史最高 9.28
- 量 比 1.00
- 振 幅 10.63%
- 歷史最低 0.2335
- 每 手 1
- 風險率 0.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
今天 10:15
D. Boral Capital Maintains Buy on VolitionRX, Lowers Price Target to $3
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $5 to $3.
12-18 20:23
VolitionRx shares are trading higher after the company issued a business review of 2025.
VolitionRx shares are trading higher after the company issued a business review...
12-18 04:50
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Agape ATP (NASDAQ:ATPC) stock rose 68.1% to $0.15 during Wednesday's r...
12-18 01:06
VolitionRx Issues 2025 Business Review
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, issues a Business Review of 2025.Review of the Year by Cameron Reynolds, Group Chief Executive OfficerAs 2025 draws to a close, I would
12-17 21:46
Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment
HENDERSON, Nev., Dec. 11, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces preprint availability of a new manuscrip...
12-11 22:00
Maxim Group Downgrades VolitionRX to Hold
Maxim Group analyst Michael Okunewitch downgrades VolitionRX (AMEX:VNRX) from Buy to Hold.
12-04 03:09
D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.
11-27 01:56
VolitionRx shares are trading higher after the company announced the first sale of its Nu.Q Cancer assays to Hospices Civils de Lyon.
VolitionRx shares are trading higher after the company announced the first sale...
11-25 21:49
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock rose 10.2% to $2.8 during Wedn...
11-20 05:07
